Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

Cited In for PubMed (Select 21439553)

1.

Schizophrenia and Depression Co-Morbidity: What We have Learned from Animal Models.

Samsom JN, Wong AH.

Front Psychiatry. 2015 Feb 18;6:13. doi: 10.3389/fpsyt.2015.00013. eCollection 2015. Review.

PMID:
25762938
Free PMC Article
2.

Maternal complement C1q and increased odds for psychosis in adult offspring.

Severance EG, Gressitt KL, Buka SL, Cannon TD, Yolken RH.

Schizophr Res. 2014 Oct;159(1):14-9. doi: 10.1016/j.schres.2014.07.053. Epub 2014 Sep 4.

PMID:
25195065
3.

Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling.

Severance EG, Yolken RH, Eaton WW.

Schizophr Res. 2014 Jul 14. pii: S0920-9964(14)00319-3. doi: 10.1016/j.schres.2014.06.027. [Epub ahead of print] Review.

PMID:
25034760
4.

Genetic underpinnings of white matter 'connectivity': heritability, risk, and heterogeneity in schizophrenia.

Voineskos AN.

Schizophr Res. 2015 Jan;161(1):50-60. doi: 10.1016/j.schres.2014.03.034. Epub 2014 Jun 2.

PMID:
24893906
5.

Multivariate analysis reveals genetic associations of the resting default mode network in psychotic bipolar disorder and schizophrenia.

Meda SA, Ruaño G, Windemuth A, O'Neil K, Berwise C, Dunn SM, Boccaccio LE, Narayanan B, Kocherla M, Sprooten E, Keshavan MS, Tamminga CA, Sweeney JA, Clementz BA, Calhoun VD, Pearlson GD.

Proc Natl Acad Sci U S A. 2014 May 13;111(19):E2066-75. doi: 10.1073/pnas.1313093111. Epub 2014 Apr 28.

6.

Role of the DLGAP2 gene encoding the SAP90/PSD-95-associated protein 2 in schizophrenia.

Li JM, Lu CL, Cheng MC, Luu SU, Hsu SH, Hu TM, Tsai HY, Chen CH.

PLoS One. 2014 Jan 8;9(1):e85373. doi: 10.1371/journal.pone.0085373. eCollection 2014.

7.

Exome sequencing of extended families with autism reveals genes shared across neurodevelopmental and neuropsychiatric disorders.

Cukier HN, Dueker ND, Slifer SH, Lee JM, Whitehead PL, Lalanne E, Leyva N, Konidari I, Gentry RC, Hulme WF, Booven DV, Mayo V, Hofmann NK, Schmidt MA, Martin ER, Haines JL, Cuccaro ML, Gilbert JR, Pericak-Vance MA.

Mol Autism. 2014 Jan 10;5(1):1. doi: 10.1186/2040-2392-5-1.

8.

Genome-wide association study of bipolar disorder in Canadian and UK populations corroborates disease loci including SYNE1 and CSMD1.

Xu W, Cohen-Woods S, Chen Q, Noor A, Knight J, Hosang G, Parikh SV, De Luca V, Tozzi F, Muglia P, Forte J, McQuillin A, Hu P, Gurling HM, Kennedy JL, McGuffin P, Farmer A, Strauss J, Vincent JB.

BMC Med Genet. 2014 Jan 4;15:2. doi: 10.1186/1471-2350-15-2.

9.

A genetic deconstruction of neurocognitive traits in schizophrenia and bipolar disorder.

Fernandes CP, Christoforou A, Giddaluru S, Ersland KM, Djurovic S, Mattheisen M, Lundervold AJ, Reinvang I, Nöthen MM, Rietschel M, Ophoff RA; Genetic Risk and Outcome of Psychosis (GROUP), Hofman A, Uitterlinden AG, Werge T, Cichon S, Espeseth T, Andreassen OA, Steen VM, Le Hellard S.

PLoS One. 2013 Dec 12;8(12):e81052. doi: 10.1371/journal.pone.0081052. eCollection 2013.

10.

Neuropsychological deficits in mice depleted of the schizophrenia susceptibility gene CSMD1.

Steen VM, Nepal C, Ersland KM, Holdhus R, Nævdal M, Ratvik SM, Skrede S, Håvik B.

PLoS One. 2013 Nov 14;8(11):e79501. doi: 10.1371/journal.pone.0079501. eCollection 2013.

11.

Innate immunity and neuroinflammation.

Shastri A, Bonifati DM, Kishore U.

Mediators Inflamm. 2013;2013:342931. doi: 10.1155/2013/342931. Epub 2013 Jun 15. Review.

12.

Identification of rare recurrent copy number variants in high-risk autism families and their prevalence in a large ASD population.

Matsunami N, Hadley D, Hensel CH, Christensen GB, Kim C, Frackelton E, Thomas K, da Silva RP, Stevens J, Baird L, Otterud B, Ho K, Varvil T, Leppert T, Lambert CG, Leppert M, Hakonarson H.

PLoS One. 2013;8(1):e52239. doi: 10.1371/journal.pone.0052239. Epub 2013 Jan 14.

13.

Assessment of behaviors modeling aspects of schizophrenia in Csmd1 mutant mice.

Distler MG, Opal MD, Dulawa SC, Palmer AA.

PLoS One. 2012;7(12):e51235. doi: 10.1371/journal.pone.0051235. Epub 2012 Dec 17.

14.

Targeted pharmacogenetic analysis of antipsychotic response in the CATIE study.

Liu Q, Jamba M, Patrick C 3rd, Padmanabhan S, Brennan MD.

Pharmacogenomics. 2012 Aug;13(11):1227-37. doi: 10.2217/pgs.12.105.

15.

The "quad-partite" synapse: microglia-synapse interactions in the developing and mature CNS.

Schafer DP, Lehrman EK, Stevens B.

Glia. 2013 Jan;61(1):24-36. doi: 10.1002/glia.22389. Epub 2012 Jul 24. Review.

16.

Complement C1q formation of immune complexes with milk caseins and wheat glutens in schizophrenia.

Severance EG, Gressitt KL, Halling M, Stallings CR, Origoni AE, Vaughan C, Khushalani S, Alaedini A, Dupont D, Dickerson FB, Yolken RH.

Neurobiol Dis. 2012 Dec;48(3):447-53. doi: 10.1016/j.nbd.2012.07.005. Epub 2012 Jul 16.

17.

GWAS reveals new recessive loci associated with non-syndromic facial clefting.

Camargo M, Rivera D, Moreno L, Lidral AC, Harper U, Jones M, Solomon BD, Roessler E, Vélez JI, Martinez AF, Chandrasekharappa SC, Arcos-Burgos M.

Eur J Med Genet. 2012 Oct;55(10):510-4. doi: 10.1016/j.ejmg.2012.06.005. Epub 2012 Jun 27.

18.

Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner.

Schafer DP, Lehrman EK, Kautzman AG, Koyama R, Mardinly AR, Yamasaki R, Ransohoff RM, Greenberg ME, Barres BA, Stevens B.

Neuron. 2012 May 24;74(4):691-705. doi: 10.1016/j.neuron.2012.03.026.

19.

DCLK1 variants are associated across schizophrenia and attention deficit/hyperactivity disorder.

Håvik B, Degenhardt FA, Johansson S, Fernandes CP, Hinney A, Scherag A, Lybæk H, Djurovic S, Christoforou A, Ersland KM, Giddaluru S, O'Donovan MC, Owen MJ, Craddock N, Mühleisen TW, Mattheisen M, Schimmelmann BG, Renner T, Warnke A, Herpertz-Dahlmann B, Sinzig J, Albayrak Ö, Rietschel M, Nöthen MM, Bramham CR, Werge T, Hebebrand J, Haavik J, Andreassen OA, Cichon S, Steen VM, Le Hellard S.

PLoS One. 2012;7(4):e35424. doi: 10.1371/journal.pone.0035424. Epub 2012 Apr 23.

20.

Gastrointestinal inflammation and associated immune activation in schizophrenia.

Severance EG, Alaedini A, Yang S, Halling M, Gressitt KL, Stallings CR, Origoni AE, Vaughan C, Khushalani S, Leweke FM, Dickerson FB, Yolken RH.

Schizophr Res. 2012 Jun;138(1):48-53. doi: 10.1016/j.schres.2012.02.025. Epub 2012 Mar 24.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk